MarketPeel
Insider Trading Intelligence
Pricing
…
CS

Clay B. Siegall

IMNM
PRESIDENT AND CEO · IMMUNOME INC. · CIK 0001167496
FILING MIX · LIFETIME78%/22%
BUYS
28
SELLS
8
TOTAL VALUE
$11.40M
COMPANIES
4
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
1,029,362
AVG SELL PX
$85.37
TRADE KIND
SHOWING 36 / 36
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
14 backtested trades · 8 horizons · 13 pending
Forward-return performance of every backtestable P/S trade by Clay B. Siegall, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d14+50.00%+7.62%+0.83%+6.79%+2.13%—
14d14+64.29%+6.21%+1.31%+4.90%+2.55%—
30d14+78.57%+3.16%+1.56%+1.60%+4.25%—
60d14+50.00%+2.64%+1.77%+0.27%+4.27%—
90d14+50.00%+10.37%+3.51%+6.87%+0.86%—
180d14(1 pending)+15.38%+28.94%+11.07%+17.87%-9.63%—
1y14(4 pending)+50.00%+50.14%+21.31%+28.83%+1.98%—
2y14(8 pending)+100.00%+1.60%+37.93%-36.33%-43.15%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IMNM · 690,704 shares · as of Mar 27, 2026
0215,131430,263645,394860,525202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 28 buys / 8 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
STTK
SHATTUCK LABS, INC.
PURCHASE
62,500$4.00$250.0K318,608Jun 9, 2026Jun 11, 2026 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
81,000——81,000May 29, 2026Jun 2, 2026 ↗View →
STTK
SHATTUCK LABS, INC.
SALE
128,054——0May 22, 2026May 27, 2026 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
128,054$1.08$138.9K256,108May 22, 2026May 27, 2026 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
President and CEO
25,450$19.67$500.6K690,704Mar 27, 2026Mar 31, 2026 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
President and CEO
4,729$21.15$100.0K665,254Dec 30, 2025Dec 30, 2025 ↗View →
IMNM
IMMUNOME INC.
SALEGRANT
Gift
200,000——660,525Dec 19, 2025Dec 22, 2025 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
President and CEO
7,278$20.48$149.1K860,525Dec 19, 2025Dec 22, 2025 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
President and CEO
46,511$21.50$1000.0K853,247Dec 18, 2025Dec 18, 2025 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
128,054——128,054Aug 25, 2025Aug 27, 2025 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
128,054$0.87$111.1K128,054Aug 25, 2025Aug 27, 2025 ↗View →
IMNM
IMMUNOME INC.
PURCHASEGRANT
Stock grant
800,000——800,000Jul 29, 2025Jul 31, 2025 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
33,150——33,150Jul 14, 2025Jul 16, 2025 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
President and CEO
137,100$7.29$999.5K806,736Mar 26, 2025Mar 26, 2025 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
President and CEO
150,000$7.75$1.16M669,636Jan 31, 2025Feb 3, 2025 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
President and CEO
33,943$9.78$331.9K519,636Nov 22, 2024Nov 23, 2024 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
President and CEO
66,057$9.54$630.3K485,693Nov 21, 2024Nov 23, 2024 ↗View →
IMNM
IMMUNOME INC.
PURCHASEGRANT
Stock grant
800,000——800,000Aug 9, 2024Aug 13, 2024 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
27,700——27,700Jun 21, 2024Jun 21, 2024 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
President and CEO
20,434$13.78$281.5K419,636May 21, 2024May 21, 2024 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
President and CEO
79,566$13.91$1.11M399,202May 20, 2024May 21, 2024 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
33,409——33,409Mar 6, 2024Mar 8, 2024 ↗View →
IMNM
IMMUNOME INC.
PURCHASE
President and CEO
169,204$5.91$1000.0K319,636Oct 2, 2023Oct 2, 2023 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
17,500——17,500May 5, 2022May 6, 2022 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
35,000——35,000May 28, 2021Jun 1, 2021 ↗View →
RARE
ULTRAGENYX PHARMACEUTICAL INC.
PURCHASE
1,596$40.37$64.4K4,146Aug 10, 2020Aug 11, 2020 ↗View →
RARE
ULTRAGENYX PHARMACEUTICAL INC.
SALE
1,596——0Aug 10, 2020Aug 11, 2020 ↗View →
RARE
ULTRAGENYX PHARMACEUTICAL INC.
SALE
1,596$85.01$135.7K2,550Aug 10, 2020Aug 11, 2020 ↗View →
RARE
ULTRAGENYX PHARMACEUTICAL INC.
SALE
9,750$85.01$828.8K2,550Aug 10, 2020Aug 11, 2020 ↗View →
RARE
ULTRAGENYX PHARMACEUTICAL INC.
SALE
23,404$85.55$2.00M12,300Aug 7, 2020Aug 11, 2020 ↗View →
RARE
ULTRAGENYX PHARMACEUTICAL INC.
SALE
17,500——0Aug 7, 2020Aug 11, 2020 ↗View →
RARE
ULTRAGENYX PHARMACEUTICAL INC.
SALE
5,904——1,596Aug 7, 2020Aug 11, 2020 ↗View →
RARE
ULTRAGENYX PHARMACEUTICAL INC.
PURCHASE
5,904$40.37$238.3K18,204Aug 7, 2020Aug 11, 2020 ↗View →
RARE
ULTRAGENYX PHARMACEUTICAL INC.
PURCHASE
17,500$21.00$367.5K35,704Aug 7, 2020Aug 11, 2020 ↗View →
RARE
ULTRAGENYX PHARMACEUTICAL INC.
PURCHASEGRANT
Stock grant
4,250——4,250Jun 26, 2020Jun 30, 2020 ↗View →
RARE
ULTRAGENYX PHARMACEUTICAL INC.
PURCHASEGRANT
Stock grant
2,550——12,300Jun 26, 2020Jun 30, 2020 ↗View →
Other insiders · IMNM
Loading peer insiders…
About this filer
CIK 0001167496
ROLE
President and CEO
PRIMARY
IMNM
COMPANIES
4
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001167496DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback